Mapping large numbers of results may take a few moments.
Search Results
Showing 301 - 350 of 528 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Luminelle | Activity: Research and Development | Company Description Luminelle developed the LUMINELLE DTx Hysteroscopy System designed for the GYN office environment. | Location Raleigh | |
Company LVM Biosciences Inc. | Activity: Research and Development | Company Description LVM Biosciences develops therapeutics for epilepsy, stroke, anxiety, migraine, and pain. | Location Chapel Hill | |
Company MAA Laboratories Inc. | Activity: Research and Development | Company Description MAA Laboratories develops new drug products by nanoformulating currently marketed drugs with meaningful clinical benefits. The company’s NanoCont technology requires small clinical trials for the new product regulatory approval through 505(b)(2) pathway. | Location Durham | |
Company Madera Therapeutics LLC | Activity: Research and Development | Company Description Madera Therapeutics is developing small molecule anti-cancer agents that function via activation of the mitochondrial protease, ClpP. Madera's TR Compounds have direct effects on bulk cancer cells and inhibit cancer stem cell function. | Location Cary | |
Company Mallinckrodt Pharmaceuticals | Activity: Production and Manufacturing | Company Description Mallinckrodt manufactures acetaminophen, the active ingredient in Tylenol, at its pharmaceutical facility in Raleigh. | Location Raleigh | |
Company Mammae Biosciences | Activity: Research and Development | Company Description Mammae Biosciences develops enzyme technologies to help food manufacturers produce prebiotic dietary fibers, including oligosaccharides. | Location Raleigh | |
Company Marius Pharmaceuticals LLC | Activity: Research and Development | Company Description Marius Pharmaceuticals develops therapeutic treatments, with a focus on oral testosterone replacement therapies for adult men symptomatic of hypogonadism. | Location Raleigh | |
Company Mastezellen Bio Inc. | Activity: Research and Development | Company Description Mastezellen Bio is developing therapeutics for the treatment of diseases and disorders with mast cell involvement. | Location Research Triangle Park | |
Company Mazen Animal Health (RTP) | Activity: Research and Development | Company Description Mazen Animal Health develops, delivers and commercializes orally-delivered biological vaccines and therapeutics for animals using recombinant DNA. | Location Durham | |
Company MDxHealth Inc. | Activity: Research and Development | Company Description MDxHealth develops epigenetic technologies to personalize the diagnosis and treatment of cancer. | Location Hillsborough | |
Company MED-EL Corporation USA | Activity: Research and Development | Company Description Med-El researches and develops cochlear implant technology. The Durham location manufactures cochlear implants and is also the North American headquarters. | Location Durham | |
Company MedPharm (Morrisville) | Activity: Production and Manufacturing | Company Description MedPharm is a CDMO that provides topical and transdermal product design, development, and manufacturing services. | Location Morrisville | |
Company MEDTOX Diagnostics Inc. | Activity: Production and Manufacturing | Company Description MEDTOX Diagnostics manufactures and distributes instant drugs of abuse testing devices for use by the government, hospital and medical centers and workplace markets. | Location Burlington | |
Company Merakris Therapeutics Inc. | Activity: Research and Development | Company Description Merakris Therapeutics develops biotherapeutic technologies derived from stem cells that promote homeostasis in damaged tissue. | Location Research Triangle Park | |
Company Merck & Co. Inc. (Durham) | Activity: Production and Manufacturing | Company Description Merck manufactures vaccine products at its Durham facility. | Location Durham | |
Company Merlon Inc. | Activity: Research and Development | Company Description Merlon develops small-molecule inhibitors for treatment of BRAF-mutated cancers resistant to BRAF and MEK inhibitors. | Location Durham | |
Company Merz Aesthetics | Activity: Research and Development | Company Description Merz Aesthetics develops injectables, devices and skincare products. | Location Raleigh | |
Company Merz Therapeutics | Activity: Research and Development | Company Description Merz Therapeutics develops and commercializes neurological therapeutic treatment solutions for patients who suffer from movement disorders and neurological health conditions. | Location Raleigh | |
Company Microscale Devices LLC | Activity: Research and Development | Company Description Microscale Devices is developing an advanced optic system for genotyping fluorophores. | Location Morrisville | |
Company MIDAS Biotech LLC | Activity: Research and Development | Company Description MIDAS Biotech develops in vitro diagnostic products. | Location Morrisville | |
Company Midnight Pharma LLC | Activity: Research and Development | Company Description Midnight Pharma is developing a treatment for insomnia. | Location Morrisville | |
Company Mind Medicine Inc. | Activity: Research and Development | Company Description Mind Medicine is a clinical-stage biopharmaceutical company developing products using the therapeutic potential of psychedelics to treat brain health disorders, with a focus on psychiatry, addiction, pain and neurology. | Location Durham | |
Company MitoRainbow Therapeutics Inc. | Activity: Research and Development | Company Description MitoRainbow is developing treatments for TK2 deficiency, a mitochondrial disease that manifests as severe myopathy. | Location Cary | |
Company Mizar Therapeutics | Activity: Research and Development | Company Description Mizar Therapeutics is a platform therapeutics company that provides drug discovery services using proprietary live-cell single-molecule imaging and machine-learning technology. | Location Chapel Hill | |
Company Mosaic Biosciences | Activity: Research and Development | Company Description Mosaic Biosciences develops new soil health solutions and provides advanced crop nutrition, specializing in plant innate immunity, plant physiology and nutrient use efficiency. | Location Durham | |
Company Mucommune LLC | Activity: Research and Development | Company Description Mucommune is developing a platform using monoclonal antibodies and mucus to reinforce the mucus barrier for female reproductive health. | Location Durham | |
Company MultiSeq Inc. | Activity: Research and Development | Company Description MultiSeq out-licenses molecular diagnostics platform technologies for cancer and infectious disease diagnosis. | Location Greensboro | |
Company Mycologics | Activity: Research and Development | Company Description Mycologics develops green antimicrobials to safeguard food, feed, and health from harmful fungal pathogens and their toxins (mycotoxins). | Location Durham | |
Company Mycorrhiza Biotech LLC | Activity: Research and Development | Company Description Mycorrhiza Biotech develops products and services to improve plant production. They specialize in fungi and allied organisms for diverse applications in agri-business. | Location Burlington | |
Company Mycosynthetix Inc. | Activity: Research and Development | Company Description Mycosynthetix manages a large collection of fungal isolates and discovers novel fungal metabolites for human and animal health and compounds for agricultural applications. | Location Hillsborough | |
Company Mycovia Pharmaceuticals Inc. | Activity: Research and Development | Company Description Mycovia Pharmaceuticals is developing therapies to treat yeast and fungal infections. | Location Durham | |
Company Myodenovo | Activity: Research and Development | Company Description Myodenovo is developing cultivated meat products. | Location Durham | |
Company NabGen Inc. | Activity: Research and Development | Company Description NabGen has developed a universal antibody suppressant technology to inhibit anti-drug and autoimmune antibodies, including suppression of pre-existing immunity and re-administration barriers to gene therapies based on adeno-associated virus (AAV) vectors. | Location Durham | |
Company Natland International Corp. | Activity: Production and Manufacturing | Company Description Natland International provides contract research synthesis of pharmaceuticals and custom organic chemicals. | Location Morrisville | |
Company Nature's Value Inc. (Winston-Salem) | Activity: Production and Manufacturing | Company Description Nature's Value is a contract nutraceutical manufacturing company. | Location Winston-Salem | |
Company Natures Crops International | Activity: Research and Development | Company Description Natures Crops supplies plant-derived ingredients from biodiverse and specialty crops to the dietary supplement, personal care and specialty nutrition industries. | Location Winston-Salem | |
Company Nelum Corp. | Activity: Research and Development | Company Description Nelum is a clinical-stage biopharmaceutical company developing patented drugs through an in-license process. Nelum´s focus is in oncology and fibrotic indications. | Location Cary | |
Company NeuroGT Inc. | Activity: Research and Development | Company Description NeuroGT is developing gene therapy products to treat rare neurogenetic diseases. | Location Chapel Hill | |
Company New Hope Biodiagnostics LLC | Activity: Research and Development | Company Description New Hope Biodiagnostics is developing biodiagnostics for cancer. | Location Chapel Hill | |
Company Nicox Ophthalmics | Activity: Research and Development | Company Description Nicox Ophthalmics develops therapeutics from a proprietary nitric-oxide research platform to help maintain vision and improve ocular health. | Location Durham | |
Company NIRvana Sciences Inc. | Activity: Research and Development | Company Description NIRvana Sciences is commercializing red and near-infrared fluorescent dyes for use in diagnostics and imaging applications. | Location Research Triangle Park | |
Company Nitta Gelatin NA Inc. (Morrisville) | Activity: Production and Manufacturing | Company Description Nitta Gelatin manufactures food, pharmaceutical and technical gelatin and is the maker of beMatrix Low Endotoxin Gelatin. beMatrix is used in the fields of regenerative medicine, medical devices and scientific research. | Location Morrisville | |
Company Nova Thin Film Pharmaceuticals LLC | Activity: Research and Development | Company Description Nova Thin Film Pharmaceuticals develops and manufactures dissolving thin film using patented DepoFilm technology to solve drug delivery challenges. | Location Greensboro | |
Company NovaCyte LLC | Activity: Research and Development | Company Description NovaCyte isolates cells from donor corneas to grow replacement corneal tissue on a scaffold as a bioengineered equivalent to the current standard of care. | Location Winston-Salem | |
Company Novartis Gene Therapies | Activity: Production and Manufacturing | Company Description Novartis Gene Therapies develops and commercializes gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The Durham site is Novartis Gene Therapies' manufacturing operations. | Location Durham | |
Company Novex Innovations LLC | Activity: Production and Manufacturing | Company Description Novex Innovations is a contract development and manufacturing organization (CDMO) supporting large, medium, small and startup life science companies in the development of their products, from concept through manufacturing and commercialization. | Location Winston-Salem | |
Company Novo Nordisk Pharmaceutical Industries LP (API facility) | Activity: Production and Manufacturing | Company Description Novo Nordisk's Active Pharmaceutical Ingredient (API) facility produces the API for an oral diabetes treatment through fermentation, purification and recovery processes. | Location Clayton | |
Company Novo Nordisk Pharmaceutical Industries LP (Durham) | Activity: Production and Manufacturing | Company Description Novo Nordisk manufactures tablets for an oral GLP-1 treatment for type 2 diabetes. | Location Durham | |
Company Novo Nordisk Pharmaceutical Industries LP (IFP facility) | Activity: Production and Manufacturing | Company Description Novo Nordisk's Clayton facility manufactures insulin, GLP-1 products and prefilled delivery devices for the treatment of diabetes. | Location Clayton | |
Company Novonesis BioAg | Activity: Research and Development | Company Description Novonesis BioAg develops microbial-based biofertility, biocontrol and bioyield enhancer products for agriculture. The Morrisville site focuses on fermentation and production technology. | Location Morrisville |